(Q24203887)

5

object named as

Michael von Bergwelt-Baildon

0 references

Sebastian Theurich

3

object named as

Sebastian Theurich

0 references

author name string

Max Schlaak

1

0 references

Juliane Pickenhain

2

0 references

Peter Kurschat

Cochrane Database of Systematic Reviews

6

0 references

publication date

18 January 2012

0 references

published in

0 references

cites work

High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Remission of refractory Sezary syndrome after bone marrow transplantation from a matched unrelated donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Treatment of cutaneous T cell lymphoma: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Nonmyeloablative hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Update on treatment of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Stem cell transplantation in advanced cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Current management strategies for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Graft-versus-leukemia effects of transplantation and donor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Current and emerging treatment strategies for cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

The allogeneic graft-versus-cancer effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Incidence of primary cutaneous T-cell lymphoma in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Incidence of skin lymphoma in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Addressing Reporting Biases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Reduced-intensity conditioning transplantation in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T Cell Lymphomas; Evidence of Graft-Versus-T Cell Lymphoma Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Analysing Data and Undertaking Meta-Analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Special Topics in Statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Selecting Studies and Collecting Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

[Successful use of allogeneic stem cell transplantation for treatment-refractory mycosis fungoides]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Effective high-dose chemotherapy combined with CD34+-selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30-negative large T cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Two cases of mycosis fungoides treated by reduced-intensity cord blood transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Cutaneous T-cell lymphoma (mycosis fungoides) relapsed with different immunological phenotype after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Short German guidelines: cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008908.PUB2

7 January 2021